Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, ACI Formulations's Enterprise Value is BDT12,317 Mil.
ACI Formulations's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was BDT712 Mil. Therefore, ACI Formulations's EV-to-EBIT ratio for today is 17.31.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, ACI Formulations's Enterprise Value is BDT12,317 Mil.
ACI Formulations's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was BDT762 Mil. Therefore, ACI Formulations's EV-to-EBITDA ratio for today is 16.15.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, ACI Formulations's Enterprise Value is BDT12,317 Mil.
ACI Formulations's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was BDT5,577 Mil. Therefore, ACI Formulations's EV-to-Revenue ratio for today is 2.21.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, ACI Formulations's Enterprise Value is BDT12,317 Mil.
ACI Formulations's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was BDT-702 Mil. Therefore, ACI Formulations's EV-to-FCF ratio for today is -17.54.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
ACI Formulations (DHA:ACIFORMULA) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
ACI Formulations's current Enterprise Value is BDT12,317 Mil.
ACI Formulations's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT712 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
ACI Formulations's current Enterprise Value is BDT12,317 Mil.
ACI Formulations's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT762 Mil.
ACI Formulations's current Enterprise Value is BDT12,317 Mil.
ACI Formulations's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT5,577 Mil.
ACI Formulations's current Enterprise Value is BDT12,317 Mil.
ACI Formulations's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-457 Mil.
ACI Formulations's current Enterprise Value is BDT12,317 Mil.
ACI Formulations's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-702 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ACI Formulations Enterprise Value Related Terms
ACI Formulations Enterprise Value Historical Data
* Premium members only.
The historical data trend for ACI Formulations's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:ACIFORMULA vs CTVA, CF, MOS: Enterprise Value Comparison
For the Agricultural Inputs subindustry, ACI Formulations's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ACI Formulations Enterprise Value vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, ACI Formulations's Enterprise Value distribution charts can be found below:
* The bar in red indicates where ACI Formulations's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
ACI Formulations's Enterprise Value for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of BDT12,317 Mil mean?
ACI Formulations (DHA:ACIFORMULA) has a Enterprise Value of BDT12,317 Mil as of Jul. 27, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on ACI Formulations and its competitors.
Is ACI Formulations' Enterprise Value too high?
ACI Formulations' current Enterprise Value is BDT12,317 Mil. Overall, ACI Formulations has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ACI Formulations' Enterprise Value compare to CTVA and CF?
ACI Formulations' Enterprise Value of BDT12,317 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for an Agriculture company?
A good Enterprise Value depends on the Agriculture industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on ACI Formulations and its competitors. ACI Formulations's current Enterprise Value is BDT12,317 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACI Formulations stock overvalued right now?
Based on GuruFocus' analysis, ACI Formulations (DHA:ACIFORMULA) is currently considered Modestly Overvalued. The stock's GF Value™ is BDT149.48, compared to a current price of BDT172.00 — trading 15.1% above its estimated fair value. The current Enterprise Value is BDT12,317 Mil. ACI Formulations' overall GF Score™ is 88/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For ACI Formulations (DHA:ACIFORMULA), the current Enterprise Value is BDT12,317 Mil as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ACI Formulations (DHA:ACIFORMULA) Overvalued in 2026?
Based on GuruFocus' analysis, ACI Formulations stock appears to be overvalued.
The current stock price of BDT172.00 is trading 15.1% above its estimated GF Value™ of BDT149.48.
GuruFocus considers ACI Formulations to be Modestly Overvalued.
Key valuation signals for DHA:ACIFORMULA:
Enterprise Value: BDT12,317 Mil
GF Value™: BDT149.48 vs. price of BDT172.00 (15.1% above fair value)
No single metric tells the full story. See the DHA:ACIFORMULA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ACI Formulations PLC is engaged in the manufacturing and marketing of several agrochemical and consumer products. The company offers a complete range of cost-effective solutions for farmers through formulating and marketing insecticides, herbicides, fungicides, miticides, etc. Its businesses are Pharmaceuticals, Salt, Skincare & Antiseptics, Kitchen Care, Fabric Care, Surface Care, Herbal Care, Lavatory Care, and Others. The group's reportable segments are Crop Care and Public Health (CC & PH), which include manufacturing and selling crop care and public health products; Mosquito coil (M. Coil) includes manufacturing and selling mosquito coil products; Aerosol provides manufacturing and selling aerosol and air freshener products; and Paint covers manufacture and sell paint products.
88GF Score
Get the complete analysis for DHA:ACIFORMULA
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:ACIFORMULA has been successfully added to your 
